secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagonist Therapeutics, Inc (PTGX)
CIK:        0001377121
Form:       8-K
Filed at:   2022-02-22T23:59:59+00:00
Accession:  0001104659-22-025661
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Protagonist Therapeutics increases inducement plan share reserve by 500,000 shares
--------------------------------------------------------------------------------

- Compensation Committee approved amendment to 2018 Inducement Plan on Feb 15, 2022, adding 500,000 shares (total 1,750,000).
- New shares reserved exclusively for inducement grants to new employees not previously employed by the company.
- Amendment adopted without stockholder approval under Nasdaq Rule 5635(c)(4) for inducement awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1377121/000110465922025661/0001104659-22-025661-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1377121/000110465922025661/tm227311d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-025661

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer